Alumil Aluminium Industry S.A. logo

Alumil Aluminium Industry S.A. (ALMY)

Market Closed
7 Aug, 14:20
ASE ASE
5. 73
-0.02
-0.3478%
- Market Cap
- P/E Ratio
- Div Yield
16,136 Volume
- Eps
5.75
Previous Close
Add Transaction
Day Range
5.66 5.79
Year Range
4.66 6.88
Want to track ALMY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ALMY closed Friday lower at €5.73, a decrease of -0.3478% from Thursday's close, completing a monthly decrease of -1.3769% or -€0.08. Over the past 12 months, ALMY stock gained 8.9354%.
ALMY pays dividends to its shareholders, with the most recent payment made on Jul 15, 2026. The next estimated payment will be in 4 weeks ago on Jul 15, 2026 for a total of €0.03.
The last earnings report, released on Apr 19, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Alumil Aluminium Industry S.A. has completed 1 stock splits, with the recent split occurring on May 11, 2000.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

ALMY Chart

Alumil Aluminium Industry S.A. (ALMY) FAQ

What is the stock price today?

The current price is €5.73.

On which exchange is it traded?

Alumil Aluminium Industry S.A. is listed on ASE.

What is its stock symbol?

The ticker symbol is ALMY.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Alumil Aluminium Industry S.A. ever had a stock split?

Alumil Aluminium Industry S.A. had 1 splits and the recent split was on May 11, 2000.

Alumil Aluminium Industry S.A. Profile

Media Industry
Communication Services Sector
D. Spencer Riley CEO
ASE Exchange
GRS289103004 ISIN
US Country
37 Employees
- Last Dividend
15 Nov 2007 Last Split
- IPO Date

Overview

Alchemy Creative, Inc. is an early-stage venture holding company that has a varied focus spanning several cutting-edge industries. Originally established in 2001 as Method Products Corp., the company underwent a significant rebranding to Alchemy Creative, Inc. in November 2007. With its headquarters based in Dallas, Texas, Alchemy Creative, Inc. positions itself at the forefront of several rapidly evolving sectors, including biopharmaceuticals, edutainment, nanotechnology, and developmental research. This diverse portfolio underlines the company’s commitment to fostering innovation and investing in areas with the potential for profound societal impact and high economic returns.

Products and Services

Alchemy Creative, Inc. offers a varied suite of products and services spanning several innovative industries:

  • Biopharmaceuticals: The company engages in the development and commercialization of new medicinal products. These efforts aim at treating diseases with a high unmet medical need, leveraging cutting-edge research and development to bring groundbreaking therapies to market.
  • Edutainment: Alchemy Creative, Inc. creates educational content that is engaging and informative, blending entertainment with educational value. This sector aims to transform traditional learning methods, making education more accessible and enjoyable for a wider audience through various media formats.
  • Nanotechnology: In the field of nanotechnology, the company is involved in the research and development of ultra-small technologies and materials. These advancements have applications in multiple industries, including electronics, healthcare, and materials science, offering the potential to revolutionize how we approach common problems and tasks.
  • Developmental Research: As part of its commitment to innovation, Alchemy Creative, Inc. is deeply invested in developmental research enterprises. This involves exploring new theories, technologies, and methodologies that could lead to the next big breakthroughs across various sectors of science and industry.

Contact Information

Address: 130 Parkhouse Street
Phone: 214 775 2424